JSW Dulux Grants 2,57,682 ESOPs at ₹2922.80 Each
JSW Dulux Limited has granted 2,57,682 ESOPs to employees under its ESOP 2026 scheme. The exercise price is set at ₹2922.80 per option, based on the market price of 12th May 2026. The grant was approved by the Nomination and Remuneration Committee on 13th May 2026.
The grant of ESOPs is a standard practice for employee incentives and typically has a minimal immediate impact on the company's stock price or overall market valuation unless the number of options granted is exceptionally large relative to the company's outstanding shares.
The announcement pertains to the grant of ESOPs, which is a routine part of employee compensation and does not inherently signal a positive or negative development for the company's financial performance or market position.
JSW Dulux Limited (formerly Akzo Nobel India Limited) announced today, 13th May 2026, that its Nomination and Remuneration Committee (NRC) has approved the grant of 2,57,682 employee stock options (ESOPs) under the JSW Dulux Limited - Employee Stock Option Scheme 2026.
These ESOPs are granted to eligible employees, with each option convertible into one equity share of the company. The exercise price for each stock option has been set at ₹2922.80, determined by the market price on 12th May 2026, the day prior to the grant date. The JSW Dulux Limited - Employee Stock Option Scheme 2026 is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The ESOPs have a vesting period of not less than one year and not more than five years from the grant date. The exercise period for vested options is a maximum of four years from the date of vesting. The company's website, www.akzonobel.co.in, will also host this information.
What to do with a filing like this
JSW Dulux Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by JSW Dulux Limited. Read the original for the full detail.